Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading GBT News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.76% | 172.50 | 1.1% | $711.75m | |
| GILD | Gilead Sciences, Inc. | 0.09% | 70.54 | 0.9% | $695.99m | |
| CELG | Celgene Corporation | 0.47% | 134.31 | 1.1% | $649.60m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.75% | 517.33 | 2.7% | $572.31m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.13% | 126.07 | 1.9% | $521.18m | |
| BIIB | Biogen Inc. | -0.09% | 280.32 | 1.2% | $500.23m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.50% | 133.50 | 1.9% | $279.31m | |
| INCY | Incyte Corporation | 0.48% | 136.28 | 2.6% | $278.87m | |
| CLVS | Clovis Oncology, Inc. | -1.84% | 95.00 | 18.0% | $249.90m | |
| TSRO | TESARO, Inc. | -2.16% | 146.53 | 14.7% | $249.01m | |
| ILMN | Illumina, Inc. | 1.25% | 185.28 | 3.5% | $164.61m | |
| BLUE | Bluebird Bio, Inc. | -5.49% | 112.00 | 19.3% | $162.00m | |
| PBYI | Puma Biotechnology, Inc. | 1.22% | 87.50 | 21.1% | $145.68m | |
| KITE | Kite Pharma, Inc. | 7.09% | 100.66 | 16.1% | $139.56m | |
| EXAS | Exact Sciences Corporation | 2.31% | 35.51 | 26.3% | $130.55m |
Company Profile
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.,0CM1LJ-E